+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 95Years
All Genders
ID06869811

Comparing Left Atrial Appendage Closure Plus Oral Anticoagulation to Oral Anticoagulation Alone for Patients with Stroke Despite Anticoagulation

Led by Hospital Clinic of Barcelona · Updated on 2025-03-11

380

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

This research focuses on patients who have had an ischemic stroke despite being treated with oral anticoagulation OAC. It aims to compare whether adding a device called left atrial appendage occlusion LAAO plus direct oral anticoagulants DOAC or OAC results in fewer cardioembolic events like strokes or arterial embolisms within 12 months compared to the best medical treatment chosen by a neurologist. The study addresses the challenge of managing patients who continue to have strokes despite current anticoagulant therapies, seeking a better balance between preventing clots and avoiding bleeding risks. Participants will be randomly assigned to one of two groups the control group receiving the best medical treatment, which may include changes or intensification of OAC or DOAC therapy, and the intervention group receiving LAAO plus DOAC or OAC unless there is a specific reason to use OAC alone. The LAAO is a device implanted in the heart to reduce stroke risk. Treatment and follow-up will continue for at least 12 months to monitor outcomes. During the study, participants will undergo regular assessments including imaging tests such as CT or 3D transesophageal echocardiography to evaluate the heart and the suitability for LAA closure. Researchers will track the occurrence of cardioembolic events and monitor safety throughout the year. Participants must be able to attend follow-up visits and provide consent. The study duration for each participant is at least one year, with data collected to evaluate the primary outcome of stroke or embolism events.

CONDITIONS

Brief Title

Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here